Bill Plovanic | Chief Financial Officer |
Andy Rasdal | Chief Executive Officer |
Kyle Rose | Canaccord |
Rick Wise | Stifel |
Good day ladies and gentlemen and welcome to the Obalon Therapeutics' Fourth Quarter and Full Year 2017 Audited Financial Results Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded. I would now like to turn the conference over to Mr. Bill Plovanic, Chief Financial Officer for Obalon.
You may begin.